Progress in Cardiovascular Diseases

Official account for Progress in Cardiovascular Diseases Journal.
Impact Factor 10.6
Ranking : #15/237 CV Journals. @ElsevierConnect

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 A nonexercise equation to predict VO2 peak in chronic heart failure: Integrating clinical variables for prognostic assessment

🔗 https://t.co/PvZafuIBl7

@Dr_Montalvo_

@Sciencedirect @ElsevierConnect

#Cardiology #CardioX #CardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Factors affecting serum neurofilament light chain in transthyretin amyloid cardiomyopathy

🔗 https://t.co/vwwLGhoKAC

@MasriAhmadMD

@Sciencedirect @ElsevierConnect

#CardioX #CardioTwitter #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Cardio-metabolic biomarkers including circulating ketone bodies and risk of incident atrial fibrillation in the multi-ethnic study of atherosclerosis (MESA)

🔗 https://t.co/wRi97ZhnHa

@paragchevli @kaushgokul @DrMichaelShapir @PrashantBhave11

#Cardiology #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Early aortic valve replacement for asymptomatic severe aortic stenosis: an updated systematic review and meta-analysis

🔗 https://t.co/whoPm7z5yl

@gpontone1 @GPontone1973 @AndreBaggi @FabioFazzari2 @ValentinaMante9

@ElsevierConnect

#CardioTwitter #CardioX #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Epicardial adipose tissue attenuation as an independent marker of cardiovascular outcomes in de novo heart failure (RECOVER-EAT)

🔗 https://t.co/siJpENQjar

@tom_marwick @ArnottClare @ChengHweeSoh1

@Sciencedirect @ElsevierConnect

#Cardiology #CardioX #CardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Inflammation and atherogenic particle burden: Joint risk without proven synergy

🔗 https://t.co/nXFjlKHZQK

@TippingTheOdds @AllanSniderman

@Sciencedirect @ElsevierConnect

#CardioTwitter #CardioX #Cardiology #CVprevention

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Back to the future: Revisiting “leave nothing behind” when managing coronary artery disease

🔗 https://t.co/LxYm7WQBJY

@FGurgoglione @BernardCortese @SBasavarajaiah @Wojciech_Wanha @drbkhia

@Sciencedirect @ElsevierConnect

#Cardiology #CardioX #CardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Relationship between pancoronary inflammation and clinical outcome: a 3-vessel OCT study

🔗 https://t.co/NM6ig2lLPo

@Sciencedirect @ElsevierConnect

#CardioX #Cardiology #CardioTwitter #CVprevention

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕🔥✍️ Editorial by @lesleejshaw & @DLBHATTMD

Changing directions on cardiovascular risk assessment by targeting young adults using comprehensive imaging and preventive care strategies

🔗 https://t.co/9OFvxzoEyU

@ElsevierConnect

#CardioTwitter #Cardiology #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Coronary CT angiography for risk stratification among young adults: Prevalence of atherosclerosis and long-term outcomes

🔗 https://t.co/GjyaG6Lnro

@ArthurShiyovich @RonBlankstein @ghoshhajra

#YesCCT #CVprevention #Cardiology #CardioTwitter #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Genetic testing for dilated and arrhythmogenic cardiomyopathies – A primer for cardiologists

🔗 https://t.co/bVuQtPWyoB

@DineshKalra

@Sciencedirect @ElsevierConnect

#CardioX #Cardiology #CardioTwitter #cardioTwitter #cardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Dynamic pericoronary fat attenuation as a non-invasive marker of CAV progression after heart transplantation

🔗 https://t.co/5eRJXRYugS

@FTona63548

@Sciencedirect @ElsevierConnect

#Cardiology #CardioTwitter #CardioX #cardiovascular

[Progress in Cardiovascular Diseases @PCVDJournal]

🔥🆕✍️ Current state of carotid artery interventions: Clinical trial results and real-world challenges

🔗 https://t.co/DeI2bO7Rzr

@HadyLichaaMD

@herbaronowMD

@Sciencedirect @ElsevierConnect

#CardioTwitter #Cardiology #CardioX #cardiovascular

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Mitral annular disjunction: rethinking a controversial arrhythmic risk marker

🔗 https://t.co/7oddesMn2N

@Figliozzis @PatrizioLancel2

@Sciencedirect @ElsevierConnect

#CardioX #Cardiology #CardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕🔥✍️ Defining inflammation in cardiovascular risk: A complex challenge

🔗 https://t.co/Erg0uXZ3nM

@ElsevierConnect @Sciencedirect

@amsterdamumc

#CardioTwitter #CardioX #Cardiology #Prevention

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Artificial intelligence for risk prediction in atherosclerotic cardiovascular disease: A narrative review of advances, validation challenges, and clinical translation (2020–2026)

🔗 https://t.co/jjuOQ0sKy5

@ElsevierConnect

#Cardiology #CardioTwitter #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✉️ Coronary CT angiography as an initial diagnostic strategy in low- to intermediate-risk NSTE-ACS: A real-world cohort study

🔗 https://t.co/hR8SOHnRlt

@paulakus6 @aguscianca @pfelissamburu @jpcostabel

@ElsevierConnect

#Cardiology #CardioTwitter #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM

🔗 https://t.co/XXYEqaovV0

@MasriAhmadMD @HeitnerStephen @DanielJacobyMD

@Sciencedirect

#CardioTwitter #CardioX #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Beyond Diet Quality for Cardiovascular Prevention: Socioeconomic Context and Unequal Cardiovascular Risk

🔗 https://t.co/hDRswszCpb

@latinoscientist @DrOstfeld @MonteHeart

@Sciencedirect @ElsevierConnect

#Cardiology #CardioX #CardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank

🔗 https://t.co/RSXLwOZBg1

@DrMichaelShapir

@Sciencedirect @ElsevierConnect

#CardioX #CardioTwitter #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Impact of cardiac rehabilitation on cardiovascular disease risk factor management at 1 and 3-year follow-up

🔗 https://t.co/kPEXKtJYC9

@J_Caldwell4

@Sciencedirect @ElsevierConnect

#Cardiology #CardioTwitter #CardioX